Characteristics of fluvoxamine-induced nausea

Psychiatry Research

Volumn 104, Issue 3, 2001, Pages 259-264

  Ueda, Nobuhisa ^a   Yoshimura, Reiji ^a   Shinkai, Koji ^a   Terao, Takeshi ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

5 Hydroxyindoleacetic acid (5 HIAA); Depression; Fluvoxamine; Mosapride; Nausea

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BENZAMIDE DERIVATIVE; FLUVOXAMINE; MOSAPRIDE CITRATE;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; MALE; NAUSEA; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; BENZAMIDES; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUVOXAMINE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; MORPHOLINES; NAUSEA; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 0035976645     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00320-1     Document Type: Article

References (25)

1. Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients
2. The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man
3. Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors
4. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: Implications for proarrhythmic potential?
5. Changes in serotonin metabolism in cancer patients: Its relationship to nausea and vomiting induced by chemotherapeutic drugs
6. Fluvoxamine and chlorimipramine in endogenous depression
7. 5-Hydroxytryptamine and human small intestinal motility: Effect of inhibiting 5-hydroxytryptamine reuptake
8. Drug interactions with newer antidepressants: Role of human cytochromes P450
9. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: A double-blind, multicentre study
10. Comparative efficacy of antidepressants
11. Biogenic amine metabolites in plasma of drug-naïve schizophrenic patients: Associations with symptomatology
12. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children
13. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: Comparison with cisapride and mosapride citrate
14. First-episode neuroleptic-free schizophrenics: Concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment
15. Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors
16. Fluvoxamine: An overview of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness
17. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
18. A comparison of fluvoxamine and fluoxetine in the treatment of major depression
19. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists
20. Adverse reactions of selective serotonin reuptake inhibitors
21. Sensitive one-step extraction procedure for column liquid chromatographic determination of fluvoxamine in human and rat plasma
22. Fluvoxamine: An updated review of its pharmacology, and therapeutic use in depressive illness
23. Determination of 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in human plasma by a simple and rapid high-performance liquid chromatography assay
24. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals